EGFR and non-small cell lung carcinoma: In the present study, we used ddPCR and NGS sequencing to analyze plasma samples, and NGS and Cobas sequencing to analyze tissue samples to identify somatic mutations in EGFR-positive NSCLC patients during disease progression.